S-EPMC10661489 - Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme - OmicsDI

Unknown

Dataset Information

Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme

ABSTRACT:

SUBMITTER: Falkai P

PROVIDER: S-EPMC10661489 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature